본문으로 이동


R&D

Korean Pharmaceutical Innovators' Group
Korea Drug Research Association

내 페이스북 계정에 현재 페이지 등록하기 트윗터에 공유하기 현재 페이지 URL 복사

New Drug Approval Status of Major Korean Pharmaceutical Companies by Therapeutic Category

Rank Category R&D Projects %
1 Antiarthritics 6 18.2
2 Anti-cancer 5 15.2
3 Antibiotics 5 15.2
4 Antiulcer 4 12.1
5 Erectile Dysfunction 3 9.1
6 Antidiabetic 3 9.1
7 Respiratory system 2 6.1
8 Liver Disease 1 3.0
9 Immunomodulator 1 3.0
10 Antihypertensive 1 3.0
11 other 2 6.1
Total 33  
※ Source : KDRA Survey over 41 Leading Pharmaceutical companies in 2014

New Drug R&D Pipelines of Major Korean Pharmaceutical Companies by Active Ingredien

Rank Classification of
Active ingredient
No. of Projects
(Active ingredients)
%
1 New Chemical Entities 117 45.9
2 New Biological Entities 83 32.5
3 Natural Products 55 21.6
Total 255 100.0
※ Source : KDRA Survey over 41 Leading Pharmaceutical companies in 2014

New Drug R&D Pipelines of Major Korean Pharmaceutical Companies by R&D Stage

※ Source : KDRA Survey over 41 Leading Pharmaceutical companies in 2014

New Drug R&D Pipelines of Major Korean Pharmaceutical Companies by Therapeutic Category

※ Source : KDRA Survey over 41 Leading Pharmaceutical companies in 2014

본문 상단으로 이동


Korea Drug Research Assocoation
Address : 24, Beodeunaru-ro 14ga-gil, Yeongdeungpo-gu, Seoul, Korea (07230), Tel. : +82-2-525-3106, Fax. : +82-2-525-3109, E-Mail : kdra@kdra.or.kr, Website : http://www.kdra.or.kr Copyright © Korea Drug Research Assocoation (KDRA). All Rights Reserved.
X
Submission Check (Login)

※ Korea Drug Research Assocoation 회원님께서는 로그인 하세요.

아이디 비밀번호